Literature DB >> 6796448

Carcinogens on regeneration. Effects of N-methyl-N'-nitro-N-nitrosoguanidine and 4-nitroquinoline-1-oxide on limb regeneration in adult newts.

P A Tsonis, G Eguchi.   

Abstract

A microcrystal (ca 5 micrograms) of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) or 4-nitroquinoline-1-oxide (4NQO) was directly administered to the regeneration blastema on day 7 after amputation of a forelimb in the newt in order to analyze the effect of such potent carcinogenic substances on regeneration cells. Although neither MNNG nor 4NQO arrested regeneration completely, they caused great retardation of the regeneration cone formation followed by various abnormalities in the bony structures. Abnormal regenerants could be classified into the following four categories; (1) complete absence of both ulna and radius; (2) subregeneration or superregeneration of carpals and digits; (3) multiple disorganization of skeletal elements; (4) arrest of regeneration at the stage of regeneration cone. The polarity of regenerants developed after application of MNNG or 4NQO was very often shifted, during which the regeneration cone was always formed from the site where a microcrystal of the carcinogens was administered. The secondary regeneration initiated by reamputation of the regenerating limb, which had received the carcinogens at the early blastema stage, proceeded in the same way as observed in the case of a simple amputation. This suggested local and temporal effects of the carcinogens applied. Nevertheless, tumor formation has not induced in the newt limb so far. We can learn from these data that both MNNG and 4NQO only alter behavior of the newt regeneration cells without excreting their carcinogenic effects on them, and that the newt cells are highly resistant and stable against the above-mentioned carcinogens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796448     DOI: 10.1111/j.1432-0436.1981.tb01155.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  11 in total

1.  Cellular electroporation induces dedifferentiation in intact newt limbs.

Authors:  Donald L Atkinson; Tamara J Stevenson; Eon Joo Park; Matthew D Riedy; Brett Milash; Shannon J Odelberg
Journal:  Dev Biol       Date:  2006-07-29       Impact factor: 3.582

Review 2.  Regeneration: The origin of cancer or a possible cure?

Authors:  Néstor J Oviedo; Wendy S Beane
Journal:  Semin Cell Dev Biol       Date:  2009-04-14       Impact factor: 7.727

3.  The regeneration of newt limbs deformed in nature.

Authors:  P A Tsonis; G Eguchi
Journal:  Experientia       Date:  1985-07-15

4.  Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.

Authors:  Brook Chernet; Michael Levin
Journal:  J Clin Exp Oncol       Date:  2013

5.  Tumor suppressors: enhancers or suppressors of regeneration?

Authors:  Jason H Pomerantz; Helen M Blau
Journal:  Development       Date:  2013-06       Impact factor: 6.868

6.  Regenerative capacity in newts is not altered by repeated regeneration and ageing.

Authors:  Goro Eguchi; Yukiko Eguchi; Kenta Nakamura; Manisha C Yadav; José Luis Millán; Panagiotis A Tsonis
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

7.  A bioinformatics expert system linking functional data to anatomical outcomes in limb regeneration.

Authors:  Daniel Lobo; Erica B Feldman; Michelle Shah; Taylor J Malone; Michael Levin
Journal:  Regeneration (Oxf)       Date:  2014-04

Review 8.  Salamanders: The molecular basis of tissue regeneration and its relevance to human disease.

Authors:  Claudia Marcela Arenas Gómez; Karen Echeverri
Journal:  Curr Top Dev Biol       Date:  2021-03-16       Impact factor: 4.897

9.  Peculiarities of carcinogenesis under simultaneous oral administration of benzo(a)pyrene and o-cresol in mice.

Authors:  N V Balenko; I A Chernichenko; V F Babiy
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

10.  Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer.

Authors:  Eric Villiard; Henner Brinkmann; Olga Moiseeva; Frédérick A Mallette; Gerardo Ferbeyre; Stéphane Roy
Journal:  BMC Evol Biol       Date:  2007-09-28       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.